CLINICAL_TRIALS
trial_result
· 2020-06-16
Clinical Trial Update: HMPL-453 in Advanced Malignant Mesothelioma [Phase 2]
Summary
Phase 2 clinical trial update for HMPL-453 in advanced malignant mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hutchison Medipharma Limited | Conditions: Advanced Malignant Mesothelioma | Phase 2 | Status: UNKNOWN